← Open Payments lookup

KATHRYN MARTIN: Open Payments

NPI 1851620116 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$150 in 8 payments from 8 companies in 2025. Trend: 2023 $364 · 2024 $68 · 2025 $150

Food & beverage: $150
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP1$25
Takeda Pharmaceuticals U.S.A., Inc.1$23
Merck Sharp & Dohme LLC1$21
Daiichi Sankyo Inc.1$20
Regeneron Healthcare Solutions, Inc.1$17
Azurity Pharmaceuticals, Inc.1$16
Bayer Healthcare Pharmaceuticals Inc.1$15
Myriad Genetic Laboratories, Inc.1$14

Products named: IMFINZI, ICLUSIG, KEYTRUDA, DATROWAY, LYNOZYFIC, DANZITEN, Nubeqa, MYRISK.

Industry payments across TX — which companies pay providers there.